• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Different behaviors of bioresorbable vascular scaffold in different types of calcified lesion: Insights from intravascular imaging.生物可吸收血管支架在不同类型钙化病变中的不同行为:来自血管内成像的见解
J Cardiol Cases. 2018 Jan 2;17(4):126-129. doi: 10.1016/j.jccase.2017.12.003. eCollection 2018 Apr.
2
Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.生物可吸收依维莫司洗脱血管支架治疗慢性完全闭塞病变:CTO-ABSORB 初步研究。
EuroIntervention. 2015 Sep;11(5):555-63. doi: 10.4244/EIJY14M12_07.
3
ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.可吸收生物降解支架与第二代金属支架比较:100 例 OCT 指导下复杂病变治疗的对比研究。
JACC Cardiovasc Interv. 2014 Jul;7(7):741-50. doi: 10.1016/j.jcin.2014.01.165.
4
Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions.复杂冠状动脉病变中生物可吸收血管支架与第二代金属药物洗脱支架的真实世界经验比较
J Invasive Cardiol. 2018 Jul;30(7):251-255. Epub 2018 Apr 15.
5
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: insights from in vitro expansion in a coronary artery lesion model.与金属平台相比,生物可吸收血管支架的径向扩张和形态:来自冠状动脉病变模型体外扩张的见解。
EuroIntervention. 2016 Sep 18;12(7):834-44. doi: 10.4244/EIJV12I7A138.
6
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.生物可吸收依维莫司洗脱支架与金属依维莫司洗脱支架治疗初发原生冠状动脉病变所致缺血性心脏病的比较(ABSORB II):一项随机对照临床试验的临床和操作次要终点 1 年中期分析。
Lancet. 2015 Jan 3;385(9962):43-54. doi: 10.1016/S0140-6736(14)61455-0. Epub 2014 Sep 14.
7
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).植入可吸收依维莫司洗脱完全生物可吸收血管支架后急性支架断裂和晚期结构不连续性的发生率和影像学结果:ABSORB 队列 B 试验的光学相干断层成像评估(生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评价)。
JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.
8
Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.经全吸收聚合物雷帕霉素洗脱支架冠状动脉植入治疗初发冠状动脉疾病患者的 5 年临床和功能多层螺旋 CT 血管造影结果:ABSORB 队列 A 试验。
JACC Cardiovasc Interv. 2013 Oct;6(10):999-1009. doi: 10.1016/j.jcin.2013.05.017.
9
Bioresorbable Scaffold for Treatment of Coronary Artery Lesions: Intravascular Ultrasound Results From the ABSORB Japan Trial.生物可吸收支架治疗冠状动脉病变:ABSORB 日本试验的血管内超声结果。
JACC Cardiovasc Interv. 2018 Apr 9;11(7):648-661. doi: 10.1016/j.jcin.2017.11.034.
10
Bioresorbable vascular scaffold implantation for severely calcified lesions after excimer laser lesion preparation.准分子激光斑块消蚀术后严重钙化病变行生物可吸收血管支架植入。
Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1283-1288. doi: 10.1002/ccd.27704. Epub 2018 Sep 30.

本文引用的文献

1
Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial.载有依维莫司的可吸收生物降解血管支架植入术后病变钙化对血管造影结果的影响:来自 ABSORB Japan 试验的观察。
EuroIntervention. 2017 Feb 20;12(14):1738-1746. doi: 10.4244/EIJ-D-16-00359.
2
Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging.支架内血栓形成的可能机械原因:冠状动脉内影像学病例报告的启示。
EuroIntervention. 2017 Feb 20;12(14):1747-1756. doi: 10.4244/EIJ-D-16-00471.
3
Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis.极晚期药物洗脱支架和裸金属支架血栓形成的失败机制及新生动脉粥样硬化模式
Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.116.003785.
4
Relationship Between Thickness of Calcium on Optical Coherence Tomography and Crack Formation After Balloon Dilatation in Calcified Plaque Requiring Rotational Atherectomy.钙化斑块行旋磨术治疗后球囊扩张时光学相干断层扫描显示的钙化厚度与裂纹形成之间的关系
Circ J. 2016 May 25;80(6):1413-9. doi: 10.1253/circj.CJ-15-1059. Epub 2016 Apr 15.
5
Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds.使用生物可吸收血管支架治疗钙化病变患者的手术结果。
EuroIntervention. 2016 Mar;11(12):1355-62. doi: 10.4244/EIJY15M03_11.
6
Agreement and reproducibility of gray-scale intravascular ultrasound and optical coherence tomography for the analysis of the bioresorbable vascular scaffold.评价生物可吸收血管支架的灰阶血管内超声和光相干断层成像的一致性和可重复性。
Catheter Cardiovasc Interv. 2012 May 1;79(6):890-902. doi: 10.1002/ccd.23108. Epub 2011 Nov 30.
7
Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions.冠状动脉疾病中的钙化模式。对1155个病变进行血管内超声和冠状动脉造影的统计分析。
Circulation. 1995 Apr 1;91(7):1959-65. doi: 10.1161/01.cir.91.7.1959.

生物可吸收血管支架在不同类型钙化病变中的不同行为:来自血管内成像的见解

Different behaviors of bioresorbable vascular scaffold in different types of calcified lesion: Insights from intravascular imaging.

作者信息

Mitomo Satoru, Tanaka Akihito, Candilio Luciano, Azzalini Lorenzo, Carlino Mauro, Latib Azeem, Colombo Antonio

机构信息

Unit of Cardiovascular Interventions, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Vita-Salute San Raffaele University, Milan, Italy.

出版信息

J Cardiol Cases. 2018 Jan 2;17(4):126-129. doi: 10.1016/j.jccase.2017.12.003. eCollection 2018 Apr.

DOI:10.1016/j.jccase.2017.12.003
PMID:30279873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6149562/
Abstract

A 55-year-old male underwent percutaneous coronary intervention (PCI) for left anterior descending artery chronic total occlusion. After lesion preparation with non-compliant (NC) balloon, two bioresorbable vascular scaffolds (2.5/28 mm, 3.0/28 mm, Absorb BVS, Abbott Vascular, Santa Clara, CA, USA) were implanted followed by 1:1 sized NC balloon post-dilatation at 20 atm. Final intravascular ultrasound (IVUS) showed acceptable BVS expansion in diffusely calcified lesions. Twenty-one months' follow-up coronary angiography revealed severe restenosis with reocclusion at the distal edge of the distal BVS. After recanalization with a 1.0 mm balloon, optical coherence tomography (OCT) was performed. Quantitative analysis comparing OCT and IVUS at the index procedure demonstrated that minimum scaffold area at follow-up became significantly smaller and with higher eccentricity, suggesting severe recoil at the lesions with thick calcium spot, whereas these changes were not observed at the lesion with relatively thin calcification. The lesions were successfully revascularized with drug-eluting stents and final OCT showed symmetric expansion of metallic stents. Our case demonstrates that different types of calcification can have an impact on BVS expansion and recoil. In calcified lesions, an optimal implantation technique is mandatory to achieve the best possible results, and characterization of calcified lesions with intravascular imaging may be helpful to decide PCI strategy with BVS. < Calcified lesions represent a challenging lesion subset for bioresorbable vascular scaffold (BVS) because of less radial strength of the latter. Quantitative analysis with intravascular imaging demonstrated that different types of calcification can have an impact on BVS expansion and recoil. In calcified lesions, an optimal implantation technique is mandatory to achieve the best possible results, and characterization of calcified lesions with intravascular imaging may be helpful to decide percutaneous coronary intervention strategy with BVS.>.

摘要

一名55岁男性因左前降支慢性完全闭塞接受经皮冠状动脉介入治疗(PCI)。在用非顺应性(NC)球囊进行病变预处理后,植入了两枚生物可吸收血管支架(2.5/28 mm、3.0/28 mm,Absorb BVS,雅培血管,美国加利福尼亚州圣克拉拉),随后在20个大气压下用尺寸为1:1的NC球囊进行后扩张。最终血管内超声(IVUS)显示在弥漫性钙化病变中生物可吸收血管支架扩张良好。21个月的随访冠状动脉造影显示严重再狭窄,远端生物可吸收血管支架远端边缘再次闭塞。在用1.0 mm球囊再通后,进行了光学相干断层扫描(OCT)。在初次手术时对OCT和IVUS进行定量分析表明,随访时支架最小面积显著变小且偏心度更高,提示在有厚钙斑的病变处有严重回缩,而在钙化相对较薄的病变处未观察到这些变化。病变通过药物洗脱支架成功实现血运重建,最终OCT显示金属支架对称扩张。我们的病例表明,不同类型的钙化可对生物可吸收血管支架的扩张和回缩产生影响。在钙化病变中,必须采用最佳植入技术以获得最佳结果,而通过血管内成像对钙化病变进行特征描述可能有助于决定使用生物可吸收血管支架的PCI策略。<钙化病变对于生物可吸收血管支架(BVS)来说是具有挑战性的病变亚组,因为后者的径向支撑力较小。血管内成像的定量分析表明,不同类型的钙化可对生物可吸收血管支架的扩张和回缩产生影响。在钙化病变中,必须采用最佳植入技术以获得最佳结果,而通过血管内成像对钙化病变进行特征描述可能有助于决定使用生物可吸收血管支架的经皮冠状动脉介入治疗策略。>